Universitat de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2019

  1. A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012–12 (EDALINE) study

    Investigational New Drugs, Vol. 37, Núm. 1, pp. 98-108

2012

  1. Sorafenib in metastatic thyroid cancer

    Endocrine-Related Cancer, Vol. 19, Núm. 2, pp. 209-216